Long-lasting ibogaine protection against NMDA-induced convulsions in mice

Neurochemical Research

Volumn 25, Issue 8, 2000, Pages 1083-1087

  Leal, M B ^a   De Souza, D O G ^a   Elisabetsky, E ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

3H MK 801 binding; Ibogaine; NMDA; NMDA induced convulsions

Indexed keywords

DIZOCILPINE; IBOGAINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; CONVULSION; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; WITHDRAWAL SYNDROME;

ANIMALS; CELL MEMBRANE; CEREBRAL CORTEX; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; IBOGAINE; MALE; MICE; MOTOR ACTIVITY; N-METHYLASPARTATE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

ANIMALIA;

EID: 0033788450     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007665911622     Document Type: Article

References (53)

1. Pharmacodynamics and therapeutic applications of iboga and ibogaine
2. Ibogaine in the treatment of chemical dependence disorders: Clinical perspectives
3. Interrupting drug dependency with ibogaine: A summary of four case histories
4. Inhibitory effects of ibogaine on cocaine self-administration in rats
5. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice
6. Effects of ibogaine on naloxone precipitated withdrawal syndrome in chronic morphine dependent rats
7. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum
8. Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremor
9. Effects and aftereffects of ibogaine on morphine self-administration in rats
10. Ibogaine reduces preference for cocaine consumption in C57BL/6 by mice
11. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies
12. Mechanisms of antiaddictive actions of ibogaine
13. Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: Interactions with D-amphetamine
14. Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum
15. Interactions of ibogaine and d-amphetamine: In vivo microdyalisis and motor behavior in rats
16. 100 Years of ibogaine: Neurochemical and pharmacological actions of a putative anti-addictive drug
17. Pharmacological screen for activities of 12-hydroxyibogamine: A primary metabolite of the indole alkaloid ibogaine
18. Glutamate receptors in the mammalian central nervous system
19. Glutamate neurotoxicity diseases of the nervous system
20. The role of glutamate in epilepsy and other CNS disorders
21. Neurotransmission in epilepsy
22. Synaptic plasticity and learning: Selective impairment of learning in rats and blockade of long-term potentation in vivo by the NMDA receptor antagonist AP5
23. Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist
24. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
25. Excitatory amino acids and drugs of abuse: A role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence
26. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine
27. Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats
28. Effect of D-cycloserine on rapid tolerance to ethanol
29. Role of NMDA receptors in pentobarbital tolerance/dependence
30. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence
31. L-1993. NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine
32. MK-801 attenuates behavioural adaptation to chronic nicotine administration in rats
33. Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists
34. 3H]dizocilpine binding in diazepam-withdrawn rats
35. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
36. Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors
37. Medication development of ibogaine as a pharmacotherapy for drug dependence
38. Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex
39. NMDA antagonist properties of the putative anti-addictive drug ibogaine
40. The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex
41. Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity
42. Ibogaine block of the NMDA receptor: In vitro and in vivo studies
43. A study of central nervous system stimulants
44. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive MDA antagonists in mice
45. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents
46. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents
47. 3H] Glutamate binding to fresh and frozen crude plasma membranes isolated from cerebral cortex of adults rats
48. Protein measurement with the Folin phenol reagent
49. 3H] MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging
50. Glutamate receptors: Brain function and signal transduction
51. Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum
52. Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration
53. Initiation and adaptation: A paradigm for understanding psychotropic drug action